Jeffrey H. Hanke, Ph.D., has been appointed to the newly created role of executive vice president, R&D, and chief scientific officer at Tesaro. Dr. Hanke will oversee non-clinical R&D organizations, as well as program management. He reports to Mary Lynne Hedley, Ph.D., president and chief operating officer of TESARO.   Dr. Hanke has more than 25 years of experience in biopharmaceutical R&D. Most recently he served as senior vice president, Research, and Global head of Biotherapeutics...